1. Helping Blood Cancer Patients Adjust to the New Normal

    Since we first learned of the rapid global spread of the coronavirus (COVID-19) the situation continues to evolve at a dizzying pace. LLS has been closely monitoring the fast-changing situation and we understand this is causing confusion and anxiety among our patients and caregivers. We previously shared some important information that blood cancer patients should know about coronavirus which you can read here. You can also visit the CDC website where you can find frequently asked questions. ...

    Read More
  2. The Power of Plant-Based Eating

    The Power of Plant-Based Eating March is National Nutrition Month®, an annual campaign created by the Academy of Nutrition and Dietetics. During the month of March, you may want to focus on the importance of making nutritious food choices and building healthy eating habits. Plant-based eating can be one way to improve your nutrition. What is plant-based eating? A Nielsen Homescan survey in 2017 found that 39% of Americans are actively trying to eat more plant-based foods. There is n...

    Read More
  3. Peripheral T-Cell Lymphoma: What to Know about this Rare Cancer, Treatment Options, and Working with the Health Care Team

    Peripheral T-cell lymphomas (PTCLs) are uncommon and aggressive types of non-Hodgkin lymphoma (NHL) that develop in mature white blood cells called “T cells” and “natural killer,” or NK, cells. Join this special educational program to hear from clinical specialists, advocates, and families facing PTCLs as they review what information is included in a pathology report, and how it is used to select therapy, why a treatment may be switched if there is a relapse and effective communicatio...

    Read More
  4. Meet the Researcher: Malathy Shanmugam, PhD, MS

    In honor of International Women’s Day on March 8, The Leukemia & Lymphoma Society (LLS) is shining a light on our community of women trailblazers who are leading the way to cancer cures. Malathy Shanmugam, PhD, MS, Winship Cancer Institute of Emory University in Atlanta, is at the forefront of finding new treatments and cures for myeloma. With support from LLS, Dr. Shanmugam is researching an innovative targeted therapy called venetoclax, which is showing promise in multiple myeloma and...

    Read More
  5. Upcoming Patient Education Programs Postponed

    Upcoming Patient Education Programs Postponed The Leukemia & Lymphoma Society (LLS) is monitoring closely the coronavirus (COVID-19) outbreak. As a health organization, one of our highest priorities is the well-being of the patients we serve, as well as our employees, volunteers, donors and partners. We are following vigilantly U.S. Centers for Disease Control and Prevention (CDC) guidelines to evaluate our plans, including upcoming events, in order to act in a timely and responsi...

    Read More
  6. FDA Approves New Therapy for Patients with Previously Treated Multiple Myeloma

    Some promising news as Myeloma Awareness Month kicks off: the U.S. Food and Drug Administration (FDA) approved today a new therapy for patients with relapsed/refractory multiple myeloma. The approval provides an important new treatment option for patients with difficult-to-treat multiple myeloma. The new therapy, called isatuximab (Sarclisa®), is approved in combination with pomalidomide and dexamethasone for the treatment of adults with multiple myeloma who have received at least two pri...

    Read More
  7. 4 Things Cancer Patients Need to Know about the Coronavirus

    coronavirus

    The Leukemia & Lymphoma Society is closely monitoring the coronavirus (COVID-19) outbreak that originated in China and is spreading to other countries around the globe. As a health organization, one of our highest priorities is the well-being of the patients we serve – especially as many blood cancer patients are immunocompromised. We are following vigilantly U.S. Centers for Disease Control and Prevention (CDC) guidelines. While there is an obvious concern right now, we encourage ...

    Read More
  8. Meet the Researcher: Omar Abdel-Wahab, MD

    This is part of a periodic series of Q&A’s with LLS-funded researchers. Dr. Abdel-Wahab of Memorial Sloan Kettering Cancer Center focuses on an area of research called epigenetics – chemical modifications that regulate (switch on and off) gene activity. He is studying how these processes drive the development of acute myeloid leukemia and other blood cancers. He currently holds a Career Development Program grant from LLS, a program that supports scientists earlier in their careers...

    Read More
  9. February Patient Education Programs

    LLS may be coming to your town! Check out the list below of our free education programs. February Surviving and Thriving with Blood Cancer February 1, 2020 – Albuquerque, NM https://www.eiseverywhere.com/512986 Texas Blood Cancer Conference 2020 February 8, 2020 – San Antonio, TX https://www.etouches.com/TXBCC20​ Meet the Doctors: An Educational Program for Patients & Caregivers February 8, 2020 – Omaha, NE https://www.eiseverywhere.com/501032 Living Well w...

    Read More
  10. Upcoming Blood Cancer Conferences

    LLS Blood Cancer Conferences are free education events for blood cancer patients, survivors, caregivers, family members and healthcare professionals to learn more about treatment options, emerging therapies, management of survivorship issues and LLS resources. Upcoming Conferences: San Francisco, CA January 25, 2020 www.etouches.com/NCABCC20 San Antonio, TX February 8, 2020 www.etouches.com/TXBCC20 Fort Lauderdale, FL February 29, 2020 www.etouches.com/FLBCC20

    Read More